Back to Stakeholders
Research, Drug Development & ManufacturingLead program: Pre-clinical
Core One LabsCSE: COOL
1 Drug Candidate
Canadian biotech developing biosynthetic psilocybin through its Vocan Biotechnologies subsidiary. Vocan's proprietary fermentation-based process produces pharmaceutical-grade psilocybin without mushroom cultivation. Signed a partnership with Cube Psytech for psychedelic drug development in December 2023.
Drug Pipeline
1Biosynthetic psilocybin (Vocan)
PsilocybinPre-clinical
Fermentation-derived pharmaceutical-grade psilocybin produced without mushroom cultivation. Developed through Vocan Biotechnologies subsidiary.
Quick Facts
- Type
- Public Biotech
- Ticker
- CSE: COOL
- Lead Stage
- Pre-clinical
- Website
- Visit